Loading clinical trials...
Loading clinical trials...
Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Treatment Retinal Vein Occlusion: a Double-blind Randomized Controlled Trial
Conditions
Interventions
Anti-VEGF drug
Mecobalamin 5 MG
+1 more
Locations
1
China
No. 1, Friendship Road, Yuanjiagang, Yuzhong District, Chongqing City
Chongqing, China
Start Date
August 1, 2025
Primary Completion Date
May 31, 2027
Completion Date
July 31, 2027
Last Updated
February 27, 2026
NCT07308639
NCT07328776
NCT07249307
NCT06879301
Lead Sponsor
First Affiliated Hospital of Chongqing Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions